$CRXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EPIRUS Biopharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in EPIRUS Biopharmaceuticals, Inc.. Get notifications about new insider transactions in EPIRUS Biopharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 24 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 7.70 | 1,000 | 7,700 | 324,429 | 325.4 K to 324.4 K (-0.31 %) |
Jul 24 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 7.69 | 1,000 | 7,690 | 325,429 | 326.4 K to 325.4 K (-0.31 %) |
Jul 24 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 7.68 | 1,000 | 7,680 | 326,429 | 327.4 K to 326.4 K (-0.31 %) |
Jul 24 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 7.63 | 1,000 | 7,630 | 327,429 | 328.4 K to 327.4 K (-0.30 %) |
Jul 24 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 7.61 | 2,000 | 15,220 | 328,429 | 330.4 K to 328.4 K (-0.61 %) |
Jul 24 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 7.57 | 1,000 | 7,570 | 330,429 | 331.4 K to 330.4 K (-0.30 %) |
Jul 24 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Buy | M | 0.87 | 10,000 | 8,694 | 331,429 | 321.4 K to 331.4 K (+3.11 %) |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | BAIRD LYNN G | Senior VP - Regulat ... | Option Exercise | A | 8.35 | 10,156 | 84,803 | 10,156 | |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | BAIRD LYNN G | Senior VP - Regulat ... | Option Exercise | A | 8.35 | 2,344 | 19,572 | 2,344 | |
Jul 21 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Option Exercise | M | 0.88 | 1,800 | 1,575 | 85,751 | |
Jul 21 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Sell | S | 8.00 | 1,800 | 14,400 | 25,000 | 26.8 K to 25 K (-6.72 %) |
Jul 21 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Buy | M | 0.88 | 1,800 | 1,575 | 26,800 | 25 K to 26.8 K (+7.20 %) |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Option Exercise | A | 8.35 | 15,234 | 127,204 | 15,234 | |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Option Exercise | A | 8.35 | 3,516 | 29,359 | 3,516 | |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Cole Jason | Senior VP & General ... | Option Exercise | A | 8.35 | 10,156 | 84,803 | 10,156 | |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Cole Jason | Senior VP & General ... | Option Exercise | A | 8.35 | 2,344 | 19,572 | 2,344 | |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Lessem Jan | Executive VP & CMO | Option Exercise | A | 8.35 | 10,547 | 88,067 | 10,547 | |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Lessem Jan | Executive VP & CMO | Option Exercise | A | 8.35 | 8,203 | 68,495 | 8,203 | |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Option Exercise | A | 8.35 | 15,234 | 127,204 | 15,234 | |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Option Exercise | A | 8.35 | 3,516 | 29,359 | 3,516 | |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Option Exercise | A | 8.35 | 20,312 | 169,605 | 20,312 | |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Option Exercise | A | 8.35 | 4,688 | 39,145 | 4,688 | |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Option Exercise | A | 8.35 | 40,625 | 339,219 | 40,625 | |
Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Option Exercise | A | 8.35 | 9,375 | 78,281 | 9,375 | |
Jul 12 2006 | CRXX | EPIRUS Biopharmace ... | Lessem Jan | Executive VP & CMO | Option Exercise | M | 0.88 | 6,000 | 5,250 | 73,319 | |
Jul 12 2006 | CRXX | EPIRUS Biopharmace ... | Lessem Jan | Executive VP & CMO | Buy | M | 0.88 | 6,000 | 5,250 | 57,714 | 51.7 K to 57.7 K (+11.60 %) |
Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Option Exercise | M | 0.87 | 7,500 | 6,521 | 30,714 | |
Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.91 | 750 | 6,683 | 67,857 | 68.6 K to 67.9 K (-1.09 %) |
Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.89 | 750 | 6,668 | 68,607 | 69.4 K to 68.6 K (-1.08 %) |
Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.87 | 750 | 6,653 | 69,357 | 70.1 K to 69.4 K (-1.07 %) |
Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.84 | 750 | 6,630 | 70,107 | 70.9 K to 70.1 K (-1.06 %) |
Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.81 | 750 | 6,608 | 70,857 | 71.6 K to 70.9 K (-1.05 %) |
Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.79 | 750 | 6,593 | 71,607 | 72.4 K to 71.6 K (-1.04 %) |
Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.76 | 750 | 6,570 | 72,357 | 73.1 K to 72.4 K (-1.03 %) |
Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.48 | 1,500 | 12,720 | 73,107 | 74.6 K to 73.1 K (-2.01 %) |
Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.42 | 750 | 6,315 | 74,607 | 75.4 K to 74.6 K (-1.00 %) |
Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Buy | M | 0.87 | 7,500 | 6,521 | 75,357 | 67.9 K to 75.4 K (+11.05 %) |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Option Exercise | M | 1.31 | 3,214 | 4,218 | 17,942 | |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Option Exercise | M | 0.88 | 1,786 | 1,563 | 26,785 | |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Option Exercise | M | 0.87 | 8,872 | 7,713 | 15,414 | |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Sell | S | 9.07 | 1,387 | 12,580 | 50,000 | 51.4 K to 50 K (-2.70 %) |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Sell | S | 8.96 | 1,387 | 12,428 | 51,387 | 52.8 K to 51.4 K (-2.63 %) |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Sell | S | 8.88 | 1,387 | 12,317 | 52,774 | 54.2 K to 52.8 K (-2.56 %) |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Sell | S | 8.76 | 1,387 | 12,150 | 54,161 | 55.5 K to 54.2 K (-2.50 %) |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Sell | S | 8.56 | 1,387 | 11,873 | 55,548 | 56.9 K to 55.5 K (-2.44 %) |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Sell | S | 8.32 | 1,387 | 11,540 | 56,935 | 58.3 K to 56.9 K (-2.38 %) |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Sell | S | 8.15 | 1,393 | 11,353 | 58,322 | 59.7 K to 58.3 K (-2.33 %) |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Sell | S | 9.18 | 1,385 | 12,714 | 59,715 | 61.1 K to 59.7 K (-2.27 %) |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Sell | S | 8.70 | 1,387 | 12,067 | 61,100 | 62.5 K to 61.1 K (-2.22 %) |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Sell | S | 8.60 | 1,385 | 11,911 | 62,487 | 63.9 K to 62.5 K (-2.17 %) |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Buy | M | 1.31 | 3,214 | 4,218 | 63,872 | 60.7 K to 63.9 K (+5.30 %) |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Buy | M | 0.87 | 8,872 | 7,713 | 60,658 | 51.8 K to 60.7 K (+17.13 %) |
Jul 10 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | SVP, Commercial Ope ... | Buy | M | 0.88 | 1,786 | 1,563 | 51,786 | 50 K to 51.8 K (+3.57 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Option Exercise | M | 0.87 | 10,000 | 8,694 | 35,714 | |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 9.11 | 1,000 | 9,110 | 321,429 | 322.4 K to 321.4 K (-0.31 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 9.06 | 1,000 | 9,060 | 322,429 | 323.4 K to 322.4 K (-0.31 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 8.99 | 1,000 | 8,990 | 323,429 | 324.4 K to 323.4 K (-0.31 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 9.15 | 1,000 | 9,150 | 324,429 | 325.4 K to 324.4 K (-0.31 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 9.10 | 1,000 | 9,100 | 325,429 | 326.4 K to 325.4 K (-0.31 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 9.09 | 1,000 | 9,090 | 326,429 | 327.4 K to 326.4 K (-0.31 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 9.06 | 1,000 | 9,060 | 327,429 | 328.4 K to 327.4 K (-0.30 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 9.05 | 2,000 | 18,100 | 328,429 | 330.4 K to 328.4 K (-0.61 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Sell | S | 8.57 | 1,000 | 8,570 | 330,429 | 331.4 K to 330.4 K (-0.30 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | CEO & President | Buy | M | 0.87 | 10,000 | 8,694 | 331,429 | 321.4 K to 331.4 K (+3.11 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Option Exercise | M | 0.88 | 1,800 | 1,575 | 169,629 | |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Sell | S | 9.11 | 180 | 1,640 | 25,000 | 25.2 K to 25 K (-0.71 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Sell | S | 8.99 | 180 | 1,618 | 25,180 | 25.4 K to 25.2 K (-0.71 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Sell | S | 8.90 | 180 | 1,602 | 25,360 | 25.5 K to 25.4 K (-0.70 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Sell | S | 9.10 | 180 | 1,638 | 25,540 | 25.7 K to 25.5 K (-0.70 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Sell | S | 9.09 | 180 | 1,636 | 25,720 | 25.9 K to 25.7 K (-0.69 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Sell | S | 9.06 | 180 | 1,631 | 25,900 | 26.1 K to 25.9 K (-0.69 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Sell | S | 9.05 | 540 | 4,887 | 26,080 | 26.6 K to 26.1 K (-2.03 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Sell | S | 8.59 | 180 | 1,546 | 26,620 | 26.8 K to 26.6 K (-0.67 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Buy | M | 0.88 | 1,800 | 1,575 | 26,800 | 25 K to 26.8 K (+7.20 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Option Exercise | M | 0.87 | 7,500 | 6,521 | 38,214 | |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.11 | 750 | 6,833 | 67,857 | 68.6 K to 67.9 K (-1.09 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.06 | 750 | 6,795 | 68,607 | 69.4 K to 68.6 K (-1.08 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.99 | 750 | 6,743 | 69,357 | 70.1 K to 69.4 K (-1.07 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.15 | 750 | 6,863 | 70,107 | 70.9 K to 70.1 K (-1.06 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.10 | 750 | 6,825 | 70,857 | 71.6 K to 70.9 K (-1.05 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.09 | 750 | 6,818 | 71,607 | 72.4 K to 71.6 K (-1.04 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.06 | 750 | 6,795 | 72,357 | 73.1 K to 72.4 K (-1.03 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.05 | 1,500 | 13,575 | 73,107 | 74.6 K to 73.1 K (-2.01 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.57 | 750 | 6,428 | 74,607 | 75.4 K to 74.6 K (-1.00 %) |
Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Buy | M | 0.87 | 7,500 | 6,521 | 75,357 | 67.9 K to 75.4 K (+11.05 %) |
Jun 05 2006 | CRXX | EPIRUS Biopharmace ... | Kauffman Michael | Director | Option Exercise | A | 8.29 | 22,857 | 189,485 | 22,857 | |
Jun 05 2006 | CRXX | EPIRUS Biopharmace ... | Deptula Barbara | Director | Option Exercise | A | 8.29 | 5,714 | 47,369 | 5,714 | |
Jun 05 2006 | CRXX | EPIRUS Biopharmace ... | FORTUNE PATRICK J | Director | Option Exercise | A | 8.29 | 5,714 | 47,369 | 5,714 | |
Jun 05 2006 | CRXX | EPIRUS Biopharmace ... | POPS RICHARD F | Director | Option Exercise | A | 8.29 | 5,714 | 47,369 | 5,714 | |
Jun 05 2006 | CRXX | EPIRUS Biopharmace ... | ALDRICH RICHARD | Director | Option Exercise | A | 8.29 | 5,714 | 47,369 | 5,714 | |
Jun 05 2006 | CRXX | EPIRUS Biopharmace ... | HAYDU FRANK | Director | Option Exercise | A | 8.29 | 5,714 | 47,369 | 5,714 | |
Apr 26 2006 | CRXX | EPIRUS Biopharmace ... | BAIRD LYNN G | Senior VP - Regulat ... | Option Exercise | A | 10.12 | 50,000 | 506,000 | 50,000 | |
Apr 26 2006 | CRXX | EPIRUS Biopharmace ... | BAIRD LYNN G | Senior VP - Regulat ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Jan 30 2006 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Jan 30 2006 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | President & CEO | Grant | A | 0.00 | 50,000 | 0 | 321,429 | 271.4 K to 321.4 K (+18.42 %) |
Jan 30 2006 | CRXX | EPIRUS Biopharmace ... | Lessem Jan | Executive VP & CMO | Grant | A | 0.00 | 15,000 | 0 | 52,857 | 37.9 K to 52.9 K (+39.62 %) |
Jan 30 2006 | CRXX | EPIRUS Biopharmace ... | Grau Daniel | Sen. VP, Commercial ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Jan 30 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Discover ... | Grant | A | 0.00 | 25,000 | 0 | 67,857 | 42.9 K to 67.9 K (+58.33 %) |
Jan 25 2006 | CRXX | EPIRUS Biopharmace ... | Cole Jason | Senior VP and Gener ... | Option Exercise | A | 10.68 | 100,000 | 1,068,000 | 100,000 | |
Dec 19 2005 | CRXX | EPIRUS Biopharmace ... | McAllister R Eric | Senior VP Clinical ... | Option Exercise | A | 8.21 | 30,000 | 246,300 | 30,000 | |
Dec 19 2005 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Discover ... | Option Exercise | A | 8.21 | 87,500 | 718,375 | 87,500 | |
Dec 19 2005 | CRXX | EPIRUS Biopharmace ... | Borisy Alexis | President & CEO | Option Exercise | A | 8.21 | 200,000 | 1,642,000 | 200,000 | |
Dec 19 2005 | CRXX | EPIRUS Biopharmace ... | Lessem Jan | Executive VP & CMO | Option Exercise | A | 8.21 | 57,500 | 472,075 | 57,500 | |
Dec 19 2005 | CRXX | EPIRUS Biopharmace ... | Forrester Robert | Executive VP & CFO | Option Exercise | A | 8.21 | 87,500 | 718,375 | 87,500 | |
Dec 19 2005 | CRXX | EPIRUS Biopharmace ... | Deptula Barbara | Director | Option Exercise | A | 8.21 | 22,857 | 187,656 | 22,857 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | YOUNG ERIC A | 10% Owner | Option Exercise | C | 0.00 | 453,861 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | YOUNG ERIC A | 10% Owner | Option Exercise | C | 0.00 | 1,588,400 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | YOUNG ERIC A | 10% Owner | Option Exercise | C | 0.00 | 1,110,300 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | YOUNG ERIC A | 10% Owner | Buy | C | 7.00 | 259,349 | 1,815,443 | 259,349 | 0 to 259.3 K |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | YOUNG ERIC A | 10% Owner | Buy | C | 7.00 | 907,653 | 6,353,571 | 907,653 | 0 to 907.7 K |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | YOUNG ERIC A | 10% Owner | Buy | C | 7.00 | 706,352 | 4,944,464 | 706,352 | 0 to 706.4 K |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Canaan Equity Partners II LLC | 10% Owner | Option Exercise | C | 0.00 | 453,861 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Canaan Equity Partners II LLC | 10% Owner | Option Exercise | C | 0.00 | 1,588,400 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Canaan Equity Partners II LLC | 10% Owner | Option Exercise | C | 0.00 | 1,110,300 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Canaan Equity Partners II LLC | 10% Owner | Buy | C | 7.00 | 259,349 | 1,815,443 | 259,349 | 0 to 259.3 K |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Canaan Equity Partners II LLC | 10% Owner | Buy | C | 7.00 | 907,653 | 6,353,571 | 907,653 | 0 to 907.7 K |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Canaan Equity Partners II LLC | 10% Owner | Buy | C | 7.00 | 706,352 | 4,944,464 | 706,352 | 0 to 706.4 K |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | RUDNICK SETH | Director | Option Exercise | C | 0.00 | 9,600 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | RUDNICK SETH | Director | Option Exercise | C | 0.00 | 6,700 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | RUDNICK SETH | Director | Buy | C | 0.00 | 5,486 | 0 | 5,486 | 0 to 5.5 K |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | RUDNICK SETH | Director | Buy | C | 0.00 | 4,263 | 0 | 4,263 | 0 to 4.3 K |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Cole Douglas | Director | Option Exercise | C | 0.00 | 518,699 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Cole Douglas | Director | Option Exercise | C | 0.00 | 1,200,000 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Cole Douglas | Director | Buy | C | 0.00 | 296,400 | 0 | 296,400 | 0 to 296.4 K |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Cole Douglas | Director | Buy | C | 0.00 | 685,715 | 0 | 685,715 | 0 to 685.7 K |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Goldfield Jacob | Director | Option Exercise | C | 0.00 | 533,333 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Goldfield Jacob | Director | Option Exercise | C | 0.00 | 11,100 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Goldfield Jacob | Director | Option Exercise | C | 0.00 | 493,350 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Goldfield Jacob | Director | Buy | C | 0.00 | 304,762 | 0 | 304,762 | 0 to 304.8 K |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Goldfield Jacob | Director | Buy | C | 0.00 | 7,061 | 0 | 7,061 | 0 to 7.1 K |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | Goldfield Jacob | Director | Buy | C | 0.00 | 339,816 | 0 | 339,816 | 0 to 339.8 K |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | FORTUNE PATRICK J | Director | Option Exercise | C | 0.00 | 2,593,496 | 0 | 0 | |
Nov 17 2005 | CRXX | EPIRUS Biopharmace ... | FORTUNE PATRICK J | Director | Buy | C | 0.00 | 1,481,996 | 0 | 1,481,996 | 0 to 1.5 M |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | TL VENTURES V LP | 10% Owner | Option Exercise | C | 0.00 | 4,409 | 0 | 0 | |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | TL VENTURES V LP | 10% Owner | Option Exercise | C | 0.00 | 254,940 | 0 | 0 | |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | TL VENTURES V LP | 10% Owner | Option Exercise | C | 0.00 | 22,669 | 0 | 0 | |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | TL VENTURES V LP | 10% Owner | Option Exercise | C | 0.00 | 1,310,664 | 0 | 0 | |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | TL VENTURES V LP | 10% Owner | Option Exercise | C | 0.00 | 22,650 | 0 | 0 | |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | TL VENTURES V LP | 10% Owner | Option Exercise | C | 0.00 | 1,311,300 | 0 | 0 | |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | TL VENTURES V LP | 10% Owner | Buy | C | 0.00 | 2,519 | 0 | 2,519 | 0 to 2.5 K |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | TL VENTURES V LP | 10% Owner | Buy | C | 0.00 | 12,954 | 0 | 12,959 | 5 to 13 K (+259,080.00 %) |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | TL VENTURES V LP | 10% Owner | Buy | C | 0.00 | 14,409 | 0 | 14,409 | 0 to 14.4 K |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | TL VENTURES V LP | 10% Owner | Buy | C | 0.00 | 145,680 | 0 | 145,680 | 0 to 145.7 K |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | TL VENTURES V LP | 10% Owner | Buy | C | 0.00 | 748,951 | 0 | 748,951 | 0 to 749 K |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | TL VENTURES V LP | 10% Owner | Buy | C | 0.00 | 834,224 | 0 | 834,224 | 0 to 834.2 K |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | MOLLER CHRISTOPHER | Director | Option Exercise | C | 0.00 | 4,409 | 0 | 0 | |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | MOLLER CHRISTOPHER | Director | Option Exercise | C | 0.00 | 254,940 | 0 | 0 | |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | MOLLER CHRISTOPHER | Director | Option Exercise | C | 0.00 | 22,669 | 0 | 0 | |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | MOLLER CHRISTOPHER | Director | Option Exercise | C | 0.00 | 1,310,664 | 0 | 0 | |
Nov 16 2005 | CRXX | EPIRUS Biopharmace ... | MOLLER CHRISTOPHER | Director | Option Exercise | C | 0.00 | 22,650 | 0 | 0 |